The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update, Proposed Transaction and RPT

27 Sep 2019 11:30

RNS Number : 9755N
Abal Group PLC
27 September 2019
 

27 September 2019

 

Abal Group Plc

("Abal" or "the Company")

 

Update, Proposed Transaction and Related Party Transaction

 

Introduction

Abal announces that it has entered into a conditional share sale and purchase agreement (the "Agreement") to acquire the entire issued and to be issued share capital of Supply@ME S.r.l., ("Supply@ME").

The proposed transaction, the principal terms of which are summarised below under the heading "Terms of the Agreement", would, because of the relative sizes of the Company and Supply@ME, constitute a reverse takeover of the Company for the purpose of Rule 14 of the AIM Rules for Companies (the "AIM Rules"). In addition, because of the relationships with certain persons in relation to both the Company and Supply@ME, the proposed transaction would constitute a related party transaction by the Company for the purpose of Rule 14 of the AIM Rules.

The Company also proposes to undertake a placing of new ordinary shares to raise new monies to provide additional funding to cover the costs of the proposed transaction and to provide working and development capital to the Company following the proposed transaction's completion.

Details of Supply@ME

Supply@ME has developed an innovative, proprietary, digital system which underpins a fintech platform that enables customer companies to carry out "inventory monetisation" transactions by transferring their unsold stock of goods to Supply@ME. This allows customers to strengthen their balance sheets while maintaining the availability of the stock of such goods so as to continue to sell them to their end customers.

Supply@Me has its headquarters in Milan and it intends to build a presence in London. It is also the intention that its services will be rolled out into other European countries in due course. Supply@Me's chief executive officer, Alessandro Zamboni, is a regulatory and digital models specialist. The intention is that he will become the Company's chief executive officer on completion of its acquisition of Supply@Me.

Terms of the Agreement

The Agreement, which was entered into on 26 September 2019, provides for the Company to acquire the entire issued and to be issued share capital of Supply@ME from the sellers for a consideration to be settled entirely by the issue of new ordinary shares in the Company. These new ordinary shares will be issued at a price of 0.6756 pence per share, being the volume weighted average price of an Abal ordinary share over the 5 business days preceding the date on which its shares were suspended from trading on AIM. No cash or other consideration will be payable by the Company. The value of the consideration to be paid, that is to say the number of new ordinary shares to be issued by Abal to the sellers of Supply@ME, will be linked and referable to the terms of the proposed placing to be undertaken by the Company and is currently therefore uncertain.

The Agreement is conditional on a number of matters, including completion of the proposed placing, shareholders' approval and completion of all necessary regulatory permissions, and the admission of the entire issued and to be issued (in respect of the Acquisition and the proposed placing) ordinary share capital of the Company to the Official List (standard segment) of the UK Listing Authority (the "Standard List") and to trading on the Main Market of London Stock Exchange Plc, for which application is expected to be made in due course. There can be no assurance that all or any of the conditions to the Agreement will be satisfied and accordingly there can be no assurance that the Agreement will complete in accordance with its terms or at all.

Regulatory disclosures

Reverse Takeover

The proposed acquisition of Supply@ME, relative to the net assets, market capitalisation and turnover of the Company, exceeds 100% of class tests contained in the AIM Rules and accordingly comprises a reverse takeover for the purpose of Rule 14 of the AIM Rules. The proposed transaction will therefore be subject to Shareholders' approval. A notice of general meeting to obtain such approval will be contained in a prospectus to be published in due course.

Related Party Transaction - The Avant Garde Group

The AvantGarde Group is interested in 92.2% of Supply@ME's issued share capital. Dominic White is a director of Eight Capital Partners PLC which is interested in 22.61% of the Company's ordinary shares. Dominic White is indirectly interested in 42% of the issued share capital of The Avant Garde Group and is therefore a related party of the Company in accordance with AIM Rule 13. Consequently, the proposed acquisition will be subject to, inter alia, agreement from that Company's independent director, Simon Charles, in consultation with the Company's nominated adviser, WH Ireland Limited, that the final terms of the transaction, once they are agreed, are fair and reasonable so far as shareholders are concerned.

Related Party Transaction - Epsion Capital

Epsion Capital Limited has been appointed as the placing agent to the Company. John Treacy, a director of the Company, is also a director of Epsion Capital Limited. John Treacy is interested in 30% of the share capital of Epsion Capital Limited. Eight Capital Partners PLC, which is interested in 22.61% of the Company's ordinary shares, is a 70% shareholder of Epsion Capital Limited. Therefore in accordance with AIM Rule 13, John Treacy and Eight Capital are each regarded as related parties and the transaction with Epsion Capital constitutes a related party transaction. Having consulted with the Company's nominated adviser, WH Ireland Limited, the independent director, Simon Charles, considers the terms of Epsion Capital Limited's appointment are fair and reasonable so far as shareholders are concerned.

Accounts for year ended 31 March 2019

In respect of the company's financial statements for the financial ended 31 March 2019, these will be published after 30 September 2019, and in conjunction with an update in respect of the potential transaction referred to above.

Trading in the Company's shares on AIM was suspended on 6 August 2019. It is currently anticipated that trading in the Company's shares will not resume until the transaction with Supply@Me is completed and the Company has been successfully admitted to the Standard List.

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

Enquiries:

Abal plc

Tel: +44 (0)7717 436384

Simon Charles

WH Ireland NOMAD and Broker

Tel: 0117 945 3471

Mike Coe / Chris Savidge

Peterhouse Capital (Joint broker)

Tel: 020 7469 0936

Lucy Williams / Duncan Vasey

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLRMMTMBTTBAL
Date   Source Headline
25th Jan 201211:30 amRNSHolding(s) in Company
23rd Jan 20127:01 amRNSContract Renewals worth £1.1m
3rd Jan 20127:00 amRNSDirectorate Change
22nd Dec 20117:00 amRNSContract extension
14th Dec 20117:00 amRNSLitigation Update
12th Dec 20117:00 amRNSContract Win
28th Nov 20117:00 amRNSHalf Yearly Report
28th Oct 20112:13 pmRNSChange of Adviser
28th Oct 201110:02 amRNSHolding(s) in Company
27th Oct 201110:45 amRNSHolding(s) in Company
13th Oct 20117:00 amRNSContract Extension
3rd Oct 201112:28 pmRNSDirectorate Change
26th Sep 20115:12 pmRNSResult of AGM
15th Sep 201110:24 amRNSHolding(s) in Company
2nd Sep 20113:25 pmRNSNotice of AGM
31st Aug 201111:46 amRNSHolding(s) in Company
26th Aug 20113:30 pmRNSResult of Open Offer and General Meeting
4th Aug 20119:32 amRNSPosting of Circular
2nd Aug 20117:15 amRNSProposed Placing, Subscription and Open Offer
2nd Aug 20117:00 amRNSFinal Results
29th Jul 201112:10 pmRNSNotice of Results
26th Apr 20117:00 amRNSIssue of Equity
14th Apr 20117:00 amRNSContract with the World Bank
1st Mar 20117:00 amRNSContract Wins and Trading Update
25th Jan 201111:22 amRNSWithdrawal of requisition of General Meeting
12th Jan 201111:01 amRNSHolding(s) in Company
11th Jan 20115:26 pmRNSIssue of Equity
22nd Dec 201012:24 pmRNSResult of General Meeting
22nd Dec 20107:00 amRNSFurther Requisition of General Meeting
16th Dec 20107:00 amRNSHalf Yearly Report
1st Dec 201010:08 amRNSNotice of General Meeting
19th Nov 20107:00 amRNSBoard Appointment
15th Nov 20103:28 pmRNSRequisition of General Meeting
11th Oct 20107:00 amRNSContract Extension with Pfizer
4th Oct 201011:58 amRNSShare Option Schemes
29th Sep 201011:41 amRNSResult of AGM
29th Sep 20107:00 amRNSAGM Statement
10th Sep 20105:00 pmRNSHolding in Company
10th Sep 20103:36 pmRNSHolding(s) in Company
10th Sep 20107:00 amRNSPilot Project Established with NASA
9th Sep 201012:47 pmRNSHolding(s) in Company
6th Sep 20104:14 pmRNSIssue of Equity
24th Aug 20103:16 pmRNSResult of General Meeting
18th Aug 20101:23 pmRNSMarket Update
6th Aug 20106:28 pmRNSPosting of Circular
30th Jul 20104:41 pmRNSHolding(s) in Company
27th Jul 20104:33 pmRNSPosting of Circular convening General Meeting
22nd Jul 201011:53 amRNSHolding(s) in Company
7th Jul 201011:04 amRNSSenior Management Team Appointments
23rd Jun 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.